166 related articles for article (PubMed ID: 7354108)
1. Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis.
Sawers JS; Toft AD; Irvine WJ; Brown NS; Seth J
J Clin Endocrinol Metab; 1980 Feb; 50(2):226-9. PubMed ID: 7354108
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
[TBL] [Abstract][Full Text] [Related]
3. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.
Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J
J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033
[No Abstract] [Full Text] [Related]
4. Thyrotoxicosis--treatment by I131 therapy and early prediction of hypothyroidism following this therapy.
Khanna CM; Jain SK; Walia RP
J Assoc Physicians India; 1994 Jan; 42(1):36-8. PubMed ID: 7836246
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
[TBL] [Abstract][Full Text] [Related]
6. Transient hypothyroidism after iodine-131 therapy for Grave's disease.
Gómez N; Gómez JM; Orti A; Gavaldà L; Villabona C; Leyes P; Soler J
J Nucl Med; 1995 Sep; 36(9):1539-42. PubMed ID: 7658207
[TBL] [Abstract][Full Text] [Related]
7. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
Konno N; Morikawa K
J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
Burch HB; Shakir F; Fitzsimmons TR; Jaques DP; Shriver CD
Thyroid; 1998 Oct; 8(10):871-80. PubMed ID: 9827653
[TBL] [Abstract][Full Text] [Related]
10. Early development of transient hypothyroidism after I131 therapy for thyrotoxicosis.
Khanna CM; Sankar R; Magdum M; Gera A
J Assoc Physicians India; 1998 Mar; 46(3):268-72. PubMed ID: 11273344
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function in patients in clinical remission after medical treatment of thyrotoxicosis.
Hooper MJ; Ratcliffe JG; Ratcliffe WA; Spencer CA; McLarty DG; Alexander WD
J Clin Endocrinol Metab; 1975 May; 40(5):807-11. PubMed ID: 47864
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function and mortality in patients treated for hyperthyroidism.
Franklyn JA; Sheppard MC; Maisonneuve P
JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
[TBL] [Abstract][Full Text] [Related]
13. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
14. Screening of geriatric patients for thyroid dysfunction with thyrotropin-releasing-hormone test, sensitive thyrotropin and free thyroxine estimation.
Szabolcs I; Ploenes C; Bernard W; Herrmann J
Horm Metab Res; 1990 May; 22(5):298-302. PubMed ID: 2112111
[TBL] [Abstract][Full Text] [Related]
15. The relationship of serum thyrotropin (TSH) to the thyroid hormones after oral TSH-releasing hormone in patients with preclinical hypothyroidism.
Staub JJ; Noelpp B; Gräni R; Gemsenjäger E; Hauenstein M; Girard J
J Clin Endocrinol Metab; 1983 Mar; 56(3):449-53. PubMed ID: 6401757
[TBL] [Abstract][Full Text] [Related]
16. Propranolol in the treatment of thyrotoxicosis by subtotal thyroidectomy.
Toft AD; Irvine WJ; McIntosh D; MacLeod DA; Seth J; Cameron EH; Lidgard GP
J Clin Endocrinol Metab; 1976 Dec; 43(6):1312-6. PubMed ID: 826544
[TBL] [Abstract][Full Text] [Related]
17. Relationship of serum T4 and T3 to TSH in primary hypothyroidism.
Ryder S; Gollapudi GM; Varma A
Arch Intern Med; 1980 Oct; 140(10):1290-1. PubMed ID: 6775609
[TBL] [Abstract][Full Text] [Related]
18. Isolated high serum triiodothyronine levels. Clinical relevance after sodium iodide I 131 therapy.
Soler NG; Kennedy W; Wortsman J
Arch Intern Med; 1979 Jan; 139(1):36-8. PubMed ID: 760681
[TBL] [Abstract][Full Text] [Related]
19. [Subclinical hypothyroidism; the start of a clinical trial into the usefulness of treatment with radioactive iodine].
Hoogendoorn EH; Wiersinga WM; Prummel MF; den Heijer M; Corstens FH; Hermus AR
Ned Tijdschr Geneeskd; 2004 May; 148(19):953-4. PubMed ID: 15160563
[TBL] [Abstract][Full Text] [Related]
20. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
